+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atropine Sulfate"

From
Antispasmodics Drugs Market Report 2025 - Product Thumbnail Image

Antispasmodics Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Ocular Inflammation Treatment Market Report 2025 - Product Thumbnail Image

Ocular Inflammation Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
Motor Neuron Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Motor Neuron Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 450 Pages
  • Global
From
Myopia - Pipeline Insight, 2024 - Product Thumbnail Image

Myopia - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
From
Low-Concentration Atropine Market 2024-2028 - Product Thumbnail Image

Low-Concentration Atropine Market 2024-2028

  • Report
  • December 2023
  • 155 Pages
  • Global
From
Loading Indicator

Atropine Sulfate is a medication used to treat a variety of cardiovascular conditions, including bradycardia, heart block, and asystole. It is a synthetic anticholinergic drug, meaning it blocks the action of acetylcholine, a neurotransmitter that helps regulate heart rate. Atropine Sulfate is administered intravenously or intramuscularly, and is available in a variety of forms, including tablets, injections, and ophthalmic solutions. It is also used to treat certain types of poisoning, such as organophosphate poisoning. Atropine Sulfate is widely used in the treatment of cardiovascular conditions, and is available from a variety of pharmaceutical companies. Some of the companies in the market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more